Dr. Rangarajan Sampath joined FIND as its Chief Scientific Officer in September 2017, where he leads the organization’s R&D and clinical departments, and will contribute to shaping and implementing FIND’s portfolio strategies. Dr. Sampath is a key member of FIND’s Executive Management team, which defines the overall business strategy and direction of the organization, mobilizing resources to enable the implementation of FIND’s mission.
Prior to this, Dr. Sampath served as a Volwiler Senior Research Fellow and Senior Director of R&D for the Ibis Division of Abbott. He led Ibis’ R&D efforts in infectious disease diagnostics, antimicrobial resistance diagnostics and surveillance, and was responsible for applications development, validation, data analysis and reporting for the Ibis PCR/ESI-MS based IRIDICA platform. Dr. Sampath was the co-founder of Ibis Biosciences, Inc. and a co-inventor of the IRIDICA (CE-IVD) infectious disease diagnostics platform.
Dr. Sampath is a recognized leader in the field, with over 200 publications and presentations and over 40 issued patents in infectious disease diagnostics. He was an invited participant at the White House National Forum on Antibiotic Stewardship and was an active member of the AdvamedDx Industry Forum for the global commitment on developing diagnostic tests to fight AMR. He has been an invited speaker at many public forums such as at the Institute of Medicine, Infectious Diseases Society of America (IDSA) and Parenteral Drug Association (PDA). He was a key member of an FDA/PDA task force involved in defining the future of viral screening for cell substrates. Dr. Sampath is currently serving his first of three-year term as a member of the Diagnostics Committee for IDSA. His research interests include antimicrobial strategy development, pathogen discovery, fevers of unknown origin, tropical diseases, epidemiological surveillance and biothreat detection.